SpecificationsOrganism/cell line/tissue*In vitro* experiments:\
 Microarray, ChIP and ATAC-sequencing: primary myoblasts (PMs)\
*In vivo* experiments:\
 RNA-sequencing: Soleus musclesSexPM and Soleus muscle samples were derived from female and male mice, respectably.Sequencer or array typeIllumina HiSeq 2500; Affymetrix Mouse Gene 1.0 ST microarraysData formatMicroarray:\
 Raw: CEL files\
ChIP and ATAC-sequencing:\
 Raw: SRA files\
 Analyzed: bed files (peak files)\
RNA-sequencing:\
 Raw: SRA files\
 Analyzed: csv file (DESeq2 differential expression)Experimental factorsTranscriptome using microarrays: 4 cultures of *Runx1*^*L/L*^[@bb0005] and *Runx1*^*f/f*^ derived PMs were used for RNA purification and transcriptome analysis.\
ChIP- and ATAC-sequencing: 2 wild type PM cultures were used for specific antibodies (Abs) and relevant controls (non-immune serum or specie-specific IgG).\
RNA-sequencing: 4 Soleus muscle samples were extracted from P60 *mdx*/*Runx1*^*L/L*^ and *mdx*/*Runx1*^*f/f*^ mice [@bb0005].Experimental featuresTranscriptome analysis was performed comparing *Runx1*^*f/f*^ PMs to *Runx1*^*L/L*^ control *in vitro*, and *mdx*/*Runx1*^*f/f*^*vs. mdx*/*Runx1*^*L/L*^*in vivo*; TF (Runx1, MyoD and c-Jun) binding and enhancer markers were examined in WT PMs.ConsentThe experiments were conducted in strict accordance with the recommendations of the US National Institutes of Health Guide for the Care and Use of Laboratory Animals [@bb0005].Sample source locationN.A.

1. Direct link to deposited data {#s0005}
================================

The data is available at the GEO database under:

<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE56131>.

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Experimental groups and design {#s0015}
-----------------------------------

To elucidate the Runx1-mediated myoblast transcriptional program during muscle regeneration, we employed genetically modified *Runx1*^*f/f*^ and *mdx*/*Runx1*^*f/f*^ mice [@bb0005]. The experimental design is schematically described in [Fig. 1](#f0005){ref-type="fig"}: First, we derived the Runx1-responsive genes by comparing the *Runx1*^*f/f*^ PM transcriptome to that of *Runx1*^*L/L*^ PMs. Next, we defined the Runx1-regulated gene subset by cross-analyzing the Runx1-responsive gene subset with genome-wide Runx1 ChIP-seq data in wild type PMs. To further characterize this Runx1-regulated gene subset we singled out Runx1-bound gene loci that were co-bound by Runx1 transcriptional collaborators MyoD and c-Jun ([Fig. 1](#f0005){ref-type="fig"}). Finally, we characterized the open/active chromatin by genome-wide mapping of active enhancer markers (H3K4me1, H3K27Ac) and ATAC-seq analyses. The combination of this comprehensive analysis generated a list of high-confidence Runx1-regulated genes. The expression profile of this high-confidence was validated *in vivo* using RNA-seq of RNA derived from muscles of *mdx*/*Runx1*^*f/f*^ *vs. mdx*/*Runx1*^*L/L*^ mice [@bb0005].

2.2. RNA purification {#s0020}
---------------------

PM cultures were established as previously described [@bb0005], [@bb0010]. For transcriptome analysis, 1e^6^--5e^6^ PMs were collected after three stages of myoblast enrichment using pre-plating, a total of 6 days post-muscle extraction. To avoid RNA degradation, the cells were washed twice with cold PBS and then subjected to flash-freezing in liquid nitrogen. RNA was isolated by the PerfectPure RNA tissue kit (\# 2302410, 5 PRIME, Germany) according to the manufacturer\'s instructions (cell culture protocol), using a rotor--stator as the disruption method (Omni-TH 02, Omni international, USA). For RNA-seq, Soleus muscles were harvested from 2 month old mice, and RNA was isolated as described above (tissue protocol, Proteinase K added).

2.3. Transcriptome analysis {#s0025}
---------------------------

For microarray analysis, purified total RNA was reverse-transcribed, amplified, and labeled with the Affymetrix GeneChip whole transcript sense target labeling kit. Labeled cDNA was analyzed using Affymetrix Mouse Gene 1.0 ST microarrays, according to the manufacturer\'s instructions. Microarray data were analyzed using the Partek Genomic Suite software. CEL files (containing raw expression measurements) were imported and data was preprocessed and normalized using the Robust Multichip Average (RMA) algorithm [@bb0015]. To identify differentially expressed genes ANOVA was applied and gene fold-changes were calculated. For RNA-seq analysis, purified total RNA was subjected to Illumina TruSeq®. RNA Sample Preparation v2 was used according to the manufacturer\'s instructions. Indexed samples were sequenced in an Illumina HiSeq 2500 machine in a single read mode. The obtained reads, 50 bp long, were mapped to the mm9 mouse genome assembly using TopHat2 [@bb0020] version 2.0.12.0.10 with default options. Expression at the gene level was quantified by HTSeq (version 0.6.1) [@bb0025], and using the known genes from the UCSC browser in General Feature Format (GFT) as annotation. Differential expression was calculated utilizing the DESeq2 software (version 1.2.10) [@bb0030].

2.4. ChIP-seq analysis {#s0030}
----------------------

For ChIP, we used WT PM cultures similar to those described above in [Section 2.2](#s0020){ref-type="sec"}. Crosse-linked chromatin from 1.2e^8^ cells (Runx1 ChIP), 6e^7^ cells (MyoD and c-Jun ChIP) and 1e^7^ cells (H3K4me1 and H3K27Ac ChIP) was prepared and fragmented to an average size of approximately 200 bp by 20--35 cycles of sonication (30 s each) in 15-ml tubes using the Bioruptor UCD-200 sonicator (Diagenode, USA). Relevant antibodies and controls are described in the Materials and methods section of [@bb0005]. DNA was purified using QIAquick spin columns (QIAGEN) and sequencing was performed using Illumina HiSeq 2500. Two biological repeats were conducted and separately sequenced for each ChIP-seq experiment. For ChIP-seq analysis, the reads were aligned to the mouse genome (mm9) allowing one mismatch and using the Bowtie aligner [@bb0035]. Reads with a unique best alignment were retained for further processing. Immunoprecipitated samples were compared against the negative control to find binding sites using the MACS2 software with the callpeak function and default parameters. The broad peak setting was used only for the histone marks [@bb0040].

2.5. ATAC-seq analysis {#s0035}
----------------------

ATAC was performed as previously described [@bb0045]. Briefly, 5 × 10^4^ PMs were harvested, and underwent the recommended transposition protocol without the lysis stage. The resulting transposed DNA was enhanced using 12 cycles of PCR, as described. The resulting libraries were sequenced using Illumina HiSeq 2500. For ATAC-seq analysis, we obtained paired-end reads of 50 bp length. Adapters were trimmed from the reads, Bowtie2 was run as previously described for ChIP-seq analysis, duplicated reads were removed using the Picard MarkDuplicates function module, and MACS2 was applied as detailed above for ChIP-seq analysis ([Section 2.4](#s0030){ref-type="sec"}).

2.6. Functional analysis {#s0040}
------------------------

The Ingenuity Pathway Analysis tool (<https://apps.ingenuity.com>/) was used for pathway and bio-function annotation of Runx1-regulated genes and the GREAT software [@bb0050] was used for ChIP-seq peak Gene Ontology (GO) analysis. The GSEA software [@bb0055] was used to perform gene set enrichment analysis on groups of genes.

3. Results & discussion {#s0045}
=======================

Skeletal muscle is a highly regenerative tissue. Upon muscle injury, the adult stem cells the satellite cells (SCs) are activated and differentiate and fuse to create myofibers that regenerate the tissue. While not expressed in healthy muscle tissue, expression of TF Runx1 significantly increases in response to various types of muscle damage including neuropathic damage [@bb0060], [@bb0065] and myopathic damage [@bb0005]. Specifically, we have recently shown that Runx1 prevents premature differentiation of SC-derived myoblasts during muscle regeneration [@bb0005]. In the myoblastic cell line C2C12 Runx1 was co-bound with the major myogenic factor, MyoD [@bb0070]. Using *in vivo* loss- and gain-of-function models and genome-wide transcriptional analyses we identify a subset of Runx1-regulateed genes that participate in muscle regeneration. Significantly, Runx1 transcriptome and ChIP-seq analysis show good correlation ([Fig. 2](#f0010){ref-type="fig"}A). Our ChIP-seq data also showed correlation with myoblast-specific transcriptional-profiling data. For example, we found that the proximity of myoblast-specific expressed genes [@bb0075] was highly enriched for co-binding of Runx1, MyoD and c-Jun (RMJ) ([Fig. 2](#f0010){ref-type="fig"}B). In addition, analysis of myoblast-specific Super-enhancers [@bb0080], revealed a strong overlap with our ChIP-seq data in sites regulating myoblast fate ([Fig. 2](#f0010){ref-type="fig"}C). Interestingly, Runx1 is involved in cell fate decision of additional adult stem cells populations, including hair follicle stem cells [@bb0085], and differentiation of mesenchymal stem cells into myofibroblasts [@bb0090]. It is conceivable that common transcription regulatory mechanisms are shared by the three systems. In summary, our data suggests that Runx1 regulates the core transcriptional program that determines myoblastic cell fate and facilitates muscle regeneration by preventing premature differentiation of proliferating myoblasts. The comprehensive data set provides a useful recourse for deciphering the molecular mechanisms underlying muscle regeneration.
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![Experimental design.\
Schematic representation of the selection procedures used to identify high-confidence Runx1-regulated genes (adapted from Umansky et al. [@bb0005]). Each cylinder represents a gene subset, with the gene number given in brackets. I --- Runx1-responsive genes were derived from *Runx1*^*L/L*^*vs. Runx1*^*f/f*^ PM microarray expression data [@bb0005]. II --- Runx1-regulated genes were derived by cross-analysis of the Runx1-responsive gene dataset and Runx1 ChIP-seq data. This gene subset represents Runx1-responsive genes that are also occupied by Runx1. III --- RMJ-regulated genes are Runx1-responsive genes that are co-occupied by Runx1, MyoD and c-Jun. IV --- High-confidence Runx1-regulated gene subset is RMJ-regulated genes that were also marked as having adjacent active regulatory elements by both anti-histone modifications (H3K4me1 & H3K27ac) ChIP-seq and ATAC-seq analysis.](gr1){#f0005}

![Correlation with previously-acquired data sets.\
(A, B) GSEA analysis of genes bound by all three TFs in comparison to Runx1-responsive genes in proliferating PMs (A) or gene expression data of WT myoblasts *vs.* differentiated myotubes (B). (C) The Runx1- and RMJ-bound loci in PM ChIP-seq were compared to published C2C12 cell line derived MyoD bound "Super enhancers" [@bb0080] loci. Percent overlapping loci of the relevant dataset are presented. C2C12 MyoD bound "Super-enhancers" compared to Runx1 and RMJ ChIP-seq. Overlap presented as percent of Super-enhancers.](gr2){#f0010}
